GlassScriptPhysician profile
Ihab Girgis
NPI 1134109895
$1,817.04
in general payments reported to CMS, 2019-2025
30 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $163 · 2021: $292 · 2022: $337 · 2023: $316 · 2024: $168 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $350.83 | 2019-2025 | Aveir, Jot Dx |
| Cvrx, INC. | $331.26 | 2022-2023 | Barostim Neo System |
| Boston Scientific Corporation | $131.99 | 2021-2025 | General - Brady |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.14 | 2022-2023 | Lifevest |
| Medtronic, INC. | $97.38 | 2025 | Linq II |
| Janssen Pharmaceuticals, INC | $83.67 | 2019-2021 | |
| Abiomed | $80.51 | 2024-2025 | Impella |
| Alnylam Pharmaceuticals INC. | $73.56 | 2025 | Onpattro |
| Irhythm Technologies, INC. | $66.20 | 2020-2022 | |
| Novo Nordisk INC | $45.94 | 2021-2024 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $41.73 | 2022-2023 | Camzyos |
| Medtronic Vascular, INC. | $36.78 | 2020 | |
| Impulse Dynamics (USA) INC. | $31.81 | 2023 | Optimizer |
| Tactile Systems Technology INC | $30.08 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Amgen INC. | $28.56 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $28.42 | 2021-2022 | |
| Atricure, INC. | $25.17 | 2024 | |
| Baxter Healthcare | $23.78 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $23.15 | 2021-2022 | |
| Scpharmaceuticals INC. | $19.35 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.16 | 2025 | |
| Pfizer INC. | $18.25 | 2024 | |
| Catheter Precision INC. | $17.21 | 2025 | |
| Potrero Medical, INC. | $17.12 | 2023 | |
| Biotronik INC. | $16.73 | 2022 | |
| Cardiva Medical, INC. | $16.69 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $14.64 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.92 | 2021 | |
| Esperion Therapeutics, INC. | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ihab Girgis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.